The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activity-Reference-Cited by-同舟云学术

The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activity

Published:2019-01-10 Issue:1 Volume:4 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Batran Rami Al,Gopal Keshav,Aburasayn Hanin,Eshreif Amina,Almutairi Malak,Greenwell Amanda A.,Campbell Scott A.,Saleme Bruno^ORCID,Court Emily A.,Eaton Farah,Light Peter E.,Sutendra Gopinath,Ussher John R.

Funder

Canadian Liver Foundation

Canadian Institutes of Health Research

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/124643/files/pdf

Reference38 articles.

1. Association of nonalcoholic fatty liver disease with insulin resistance

2. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes

3. Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease

4. The impact of current and novel anti-diabetic therapies on cardiovascular risk

5. Cardiovascular safety and diabetes drug development

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative Stress, Inflammation, and Mitochondrial Dysfunction: A Link between Obesity and Atrial Fibrillation;Antioxidants;2024-01-17

2. A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice;Experimental Physiology;2024-01-09

3. The antianginal ranolazine fails to improve glycaemia in obese liver‐specific pyruvate dehydrogenase deficient male mice;Basic & Clinical Pharmacology & Toxicology;2023-06-22

4. Effects of ranolazine on right ventricular function, fluid dynamics, and metabolism in patients with precapillary pulmonary hypertension: insights from a longitudinal, randomized, double-blinded, placebo controlled, multicenter study;Frontiers in Cardiovascular Medicine;2023-06-13

5. The pyruvate dehydrogenase complex: Life’s essential, vulnerable and druggable energy homeostat;Mitochondrion;2023-05